Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 383, Issue 1, 2011, Pages 1-11

  Herzog, Melanie ^a   Storch, Caroline Henrike ^a   Gut, Philipp ^a   Kotlyar, Dimitry ^a   Füllekrug, Joachim ^a   Ehehalt, Robert ^a   Haefeli, Walter Emil ^a   Weiss, Johanna ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ABCG2; BCRP; Caveolin 1; Knockdown; Resistance

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CAVEOLIN 1; MITOXANTRONE; PHEOPHORBIDE; VINCRISTINE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL ASSAY; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DOWN REGULATION; DRUG SENSITIVITY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RETROVIRUS; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CAVEOLIN 1; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CHLOROPHYLL; DOGS; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE MICRODOMAINS; MITOXANTRONE; NEOPLASM PROTEINS; RADIATION-SENSITIZING AGENTS; TRANSDUCTION, GENETIC; TRANSFECTION; VINCRISTINE;

EID: 78751631885     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0568-8     Document Type: Article

References (34)

1. BL Abbott 2006 ABCG2 (BCRP) a cytoprotectant in normal and malignant stem cells Clin Adv Hematol Oncol 4 63 72 16562373
2. N Albermann FH Schmitz-Winnenthal K Z'graggen C Volk MM Hoffmann WE Haefeli J Weiss 2005 Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver Biochem Pharmacol 70 949 958 1:CAS:528:DC%2BD2MXnslOqurk%3D 10.1016/j.bcp.2005.06.018 16054595 (Pubitemid 41138860)
3. S Barakat S Turcotte M Demeule M-P Lachambre A Régina LG Baggetto R Béliveau 2008 Regulation of brain endothelial cell migration and angiogenesis by P-glycoprotein/caveolin-1 interaction Biochem Biophys Res Commun 372 440 446 1:CAS:528:DC%2BD1cXnt1Oru78%3D 10.1016/j.bbrc.2008.05.012 18485890
4. Z Benderra AM Faussat L Sayada JY Perrot R Tang D Chaoui H Morjani C Marzac JP Marie O Legrand 2005 MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia Clin Cancer Res 11 7764 7772 1:CAS:528:DC%2BD2MXhtF2isL7J 10.1158/1078-0432.CCR-04-1895 16278398 (Pubitemid 41611620)
5. D Brown 2006 Lipid rafts, detergent-resistant membranes, and raft targeting signals Physiology 21 430 439 1:CAS:528:DC%2BD2sXitF2nug%3D%3D 10.1152/physiol.00032.2006 17119156 (Pubitemid 44879252)
6. C Cai J Chen 2004 Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells Int J Cancer 111 522 529 1:CAS:528:DC%2BD2cXmsFeqtbs%3D 10.1002/ijc.20300 15239129 (Pubitemid 39045318)
7. L Candeil I Gourdier D Peyron N Vezzio V Copois F Bibeau B Orsetti GL Scheffer M Ychou QA Khan Y Pommier B Pau P Martineau M Del Rio 2004 ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases Int J Cancer 109 848 854 1:CAS:528:DC%2BD2cXjt1ensrc%3D 10.1002/ijc.20032 15027118 (Pubitemid 38500741)
8. J Couet L Shengwen T Okamoto T Ikezu MP Lisanti 1997 Identification of peptide and protein ligands for the caveolin-scaffolding domain J Biol Chem 272 6525 6533 1:CAS:528:DyaK2sXhvVOlsro%3D 10.1074/jbc.272.48.30429 9045678 (Pubitemid 27512253)
9. M Dean A Rzhetsky R Allikmets 2001 The human ATP-binding cassette (ABC) transporter superfamily Genome Res 11 1156 1166 1:CAS:528:DC%2BD3MXltFaitL0%3D 10.1101/gr.GR-1649R 11435397 (Pubitemid 32677289)
10. M Dean T Fojo S Bates 2005 Tumour stem cells and drug resistance Nat Rev Cancer 5 275 284 1:CAS:528:DC%2BD2MXivVarsL4%3D 10.1038/nrc1590 15803154 (Pubitemid 40488633)
11. JE Diestra GL Scheffer I Català M Maliepaard JH Schellens RJ Scheper JR Germà-Lluch MA Izquierdo 2002 Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material J Pathol 198 213 219 1:CAS:528:DC%2BD3sXivV2jsrY%3D 10.1002/path.1203 12237881 (Pubitemid 35243879)
12. JW Hinrichs K Klappe I Hummel JW Kok 2004 ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells J Biol Chem 279 5734 5738 1:CAS:528:DC%2BD2cXhtFCjsr8%3D 10.1074/jbc.M306857200 14627714 (Pubitemid 38220603)
13. R Hnasko MP Lisanti 2003 The biology of caveolae: lessons from caveolin knockout mice and implications for human disease Mol Interv 3 445 464 1:CAS:528:DC%2BD2cXmsl2msrc%3D 10.1124/mi.3.8.445 14993453
14. JP Gillet T Efferth J Remacle 2007 Chemotherapy-induced resistance by ATP-binding cassette transporter genes Biochim Biophys Acta 1775 237 262 1:CAS:528:DC%2BD2sXmsFKmtLY%3D 17572300
15. M Kirkham RG Parton 2005 Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers Biochim Biophys Acta 1746 350 363 1:CAS:528:DC%2BD2MXhtlCqtLjO 10.1016/j.bbamcr.2005.11.007
16. P Krishnamurthy JD Schuetz 2006 Role of ABCG2/BCRP in biology and medicine Annu Rev Pharmacol Toxicol 46 381 410 1:CAS:528:DC%2BD28XisFKltbg%3D 10.1146/annurev.pharmtox.46.120604.141238 16402910 (Pubitemid 43271195)
17. Y Lavie G Fiucci M Liscovitch 1998 Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells J Biol Chem 273 32380 32383 1:CAS:528:DyaK1cXnvFOnsLc%3D 10.1074/jbc.273.49.32380 9829965 (Pubitemid 28557607)
18. Y Lavie G Fiucci M Liscovitch 2001 Upregulation of caveolin in multidrug resistance cancer cells: functional implications Adv Drug Deliv Rev 49 317 323 1:CAS:528:DC%2BD3MXlsF2js74%3D 10.1016/S0169-409X(01)00144-2 11551402 (Pubitemid 32718691)
19. Q Mao JD Unadkat 2005 Role of the breast cancer resistance protein (ABCG2) in drug transport AAPS J 7 E118 E133 1:CAS:528:DC%2BD2MXltlOqtrs%3D 10.1208/aapsj070112 16146333 (Pubitemid 41554295)
20. M Murata J Peranen R Schreiner F Weiland T Kurzchalia K Simons 1995 VIP21/caveolin is a cholesterol-binding protein Proc Natl Acad Sci USA 92 10339 10343 1:CAS:528:DyaK2MXovFalt74%3D 10.1073/pnas.92.22.10339 7479780
21. S Orlowski S Martin A Escargueil 2006 P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?) Cell Mol Life Sci 63 1038 1059 1:CAS:528:DC%2BD28XlsFags74%3D 10.1007/s00018-005-5554-9 16721513 (Pubitemid 43800774)
22. Á Pál D Méhn É Molnár S Gedey P Mészáros T Nagy H Glavinas T Janáky O von Richter G Báthori L Szente P Krajcsi 2007 Cholesterol potentiates ABCG2 activity in a heterologous expression system-improved in vitro model to study function of human ABCG2 J Pharmacol Exp Ther 321 1085 1094 10.1124/jpet.106.119289 17347325 (Pubitemid 46762703)
23. P Pavek G Merino E Wagenaar E Bolscher M Novotna JW Jonker AH Schinkel 2005 Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine, and transport of cimetidine J Pharmacol Exp Ther 312 144 152 1:CAS:528:DC%2BD2MXhtVWmt7c%3D 10.1124/jpet.104.073916 15365089 (Pubitemid 40096463)
24. T Peters H Lindenmaier WE Haefeli J Weiss 2006 Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein Naunyn-Schmiedeberg's Arch Pharmacol 372 291 299 1:CAS:528:DC%2BD28XltVSjsw%3D%3D 10.1007/s00210-005-0022-5 (Pubitemid 43119563)
25. SK Rabindran H He M Singh E Brown KI Collins T Annable LM Greenberger 1998 Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C Cancer Res 58 5850 5858 1:CAS:528:DyaK1MXivFah 9865745
26. A Sauerbrey W Sell D Steinbach A Voigt F Zintl 2002 Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia Br J Haematol 118 147 150 1:CAS:528:DC%2BD38XmtlWqsr0%3D 10.1046/j.1365-2141.2002. 03550.x 12100141 (Pubitemid 34779530)
27. S Schuck A Manninen M Honsho J Füllekrug K Simons 2004 Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference Proc Natl Acad Sci USA 101 4912 4917 1:CAS:528:DC%2BD2cXjsFCisr0%3D 10.1073/pnas.0401285101 15051873 (Pubitemid 38469177)
28. C Schwencke RC Braun-Dullaeus C Wunderlich RH Strasser 2006 Caveolae and caveolin in transmembrane signaling: implications for human disease Cardiovasc Res 70 42 49 1:CAS:528:DC%2BD28XivVejtrs%3D 10.1016/j.cardiores.2005.11.029 16412403
29. M Shatz M Liscovitch 2008 Caveolin-1: a tumor-promoting role in human cancer Int J Radiat Biol 84 177 189 1:CAS:528:DC%2BD1cXitleku7Y%3D 10.1080/09553000701745293 18300018 (Pubitemid 351323417)
30. EJ Smart YS Ying WC Donzell RGW Anderson 1996 A role for caveolin in transport of cholesterol from the endoplasmatic reticulum to plasma membrane J Biol Chem 271 29427 29435 1:CAS:528:DyaK28XntFKqs70%3D 10.1074/jbc.271.11.6518 8910609 (Pubitemid 26095467)
31. CH Storch R Ehehalt WE Haefeli J Weiss 2007 Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro J Pharmacol Exp Ther 323 257 264 1:CAS:528:DC%2BD2sXhtFahsb7O 10.1124/jpet.107.122994 17652262 (Pubitemid 47443266)
32. G Szakács JK Paterson JA Ludwig C Booth-Genthe MM Gottesman 2006 Targeting multidrug resistance in cancer Nat Rev Drug Discov 5 219 234 10.1038/nrd1984 16518375 (Pubitemid 43336035)
33. A Telbisz M Müller C Özvegy-Laczka L Homolya L Szente A Váradi B Sarkadi 2007 Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter Biochim Biophys Acta 1768 2698 2713 1:CAS:528:DC%2BD2sXht12gurfJ 10.1016/j.bbamem.2007.06.026 17662239 (Pubitemid 350081032)
34. K Yoh G Ishii T Yokose Y Minegishi K Tsuta K Goto Y Nishiwaki T Kodama M Suga A Ochiai 2004 Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer Clin Cancer Res 10 1691 1697 1:CAS:528:DC%2BD2cXhvFCltr0%3D 10.1158/1078-0432.CCR-0937-3 15014021 (Pubitemid 38435560)